Cargando…

Simulating the efficacy of vaccines on the epidemiological dynamics of SARS-CoV-2 in a membrane computing model

Membrane computing is a natural computing procedure inspired in the compartmental structure of living cells. This approach allows mimicking the complex structure of biological processes, and, when applied to transmissible diseases, can simulate a virtual ‘epidemic’ based on interactions between elem...

Descripción completa

Detalles Bibliográficos
Autores principales: Campos, Marcelino, Sempere, José M, Galán, Juan C, Moya, Andrés, Cantón, Rafael, Llorens, Carlos, Baquero, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117710/
https://www.ncbi.nlm.nih.gov/pubmed/37223355
http://dx.doi.org/10.1093/femsml/uqac018
_version_ 1785028649191211008
author Campos, Marcelino
Sempere, José M
Galán, Juan C
Moya, Andrés
Cantón, Rafael
Llorens, Carlos
Baquero, Fernando
author_facet Campos, Marcelino
Sempere, José M
Galán, Juan C
Moya, Andrés
Cantón, Rafael
Llorens, Carlos
Baquero, Fernando
author_sort Campos, Marcelino
collection PubMed
description Membrane computing is a natural computing procedure inspired in the compartmental structure of living cells. This approach allows mimicking the complex structure of biological processes, and, when applied to transmissible diseases, can simulate a virtual ‘epidemic’ based on interactions between elements within the computational model according to established conditions. General and focused vaccination strategies for controlling SARS-Cov-2 epidemics have been simulated for 2.3 years from the emergence of the epidemic in a hypothetical town of 10320 inhabitants in a country with mean European demographics where COVID-19 is imported. The age and immunological-response groups of the hosts and their lifestyles were minutely examined. The duration of natural, acquired immunity influenced the results; the shorter the duration, the more endemic the process, resulting in higher mortality, particularly among elderly individuals. During epidemic valleys between waves, the proportion of infected patients belonging to symptomatic groups (mostly elderly) increased in the total population, a population that largely benefits from standard double vaccination, particularly with boosters. There was no clear difference when comparing booster shots provided at 4 or 6 months after standard double-dose vaccination. Vaccines even of moderate efficacy (short-term protection) were effective in decreasing the number of symptomatic cases. Generalized vaccination of the entire population (all ages) added little benefit to overall mortality rates, and this situation also applied for generalized lockdowns. Elderly-only vaccination and lockdowns, even without general interventions directed to reduce population transmission, is sufficient for dramatically reducing mortality.
format Online
Article
Text
id pubmed-10117710
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101177102023-05-23 Simulating the efficacy of vaccines on the epidemiological dynamics of SARS-CoV-2 in a membrane computing model Campos, Marcelino Sempere, José M Galán, Juan C Moya, Andrés Cantón, Rafael Llorens, Carlos Baquero, Fernando Microlife Research Article Membrane computing is a natural computing procedure inspired in the compartmental structure of living cells. This approach allows mimicking the complex structure of biological processes, and, when applied to transmissible diseases, can simulate a virtual ‘epidemic’ based on interactions between elements within the computational model according to established conditions. General and focused vaccination strategies for controlling SARS-Cov-2 epidemics have been simulated for 2.3 years from the emergence of the epidemic in a hypothetical town of 10320 inhabitants in a country with mean European demographics where COVID-19 is imported. The age and immunological-response groups of the hosts and their lifestyles were minutely examined. The duration of natural, acquired immunity influenced the results; the shorter the duration, the more endemic the process, resulting in higher mortality, particularly among elderly individuals. During epidemic valleys between waves, the proportion of infected patients belonging to symptomatic groups (mostly elderly) increased in the total population, a population that largely benefits from standard double vaccination, particularly with boosters. There was no clear difference when comparing booster shots provided at 4 or 6 months after standard double-dose vaccination. Vaccines even of moderate efficacy (short-term protection) were effective in decreasing the number of symptomatic cases. Generalized vaccination of the entire population (all ages) added little benefit to overall mortality rates, and this situation also applied for generalized lockdowns. Elderly-only vaccination and lockdowns, even without general interventions directed to reduce population transmission, is sufficient for dramatically reducing mortality. Oxford University Press 2022-09-16 /pmc/articles/PMC10117710/ /pubmed/37223355 http://dx.doi.org/10.1093/femsml/uqac018 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of FEMS. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Campos, Marcelino
Sempere, José M
Galán, Juan C
Moya, Andrés
Cantón, Rafael
Llorens, Carlos
Baquero, Fernando
Simulating the efficacy of vaccines on the epidemiological dynamics of SARS-CoV-2 in a membrane computing model
title Simulating the efficacy of vaccines on the epidemiological dynamics of SARS-CoV-2 in a membrane computing model
title_full Simulating the efficacy of vaccines on the epidemiological dynamics of SARS-CoV-2 in a membrane computing model
title_fullStr Simulating the efficacy of vaccines on the epidemiological dynamics of SARS-CoV-2 in a membrane computing model
title_full_unstemmed Simulating the efficacy of vaccines on the epidemiological dynamics of SARS-CoV-2 in a membrane computing model
title_short Simulating the efficacy of vaccines on the epidemiological dynamics of SARS-CoV-2 in a membrane computing model
title_sort simulating the efficacy of vaccines on the epidemiological dynamics of sars-cov-2 in a membrane computing model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117710/
https://www.ncbi.nlm.nih.gov/pubmed/37223355
http://dx.doi.org/10.1093/femsml/uqac018
work_keys_str_mv AT camposmarcelino simulatingtheefficacyofvaccinesontheepidemiologicaldynamicsofsarscov2inamembranecomputingmodel
AT semperejosem simulatingtheefficacyofvaccinesontheepidemiologicaldynamicsofsarscov2inamembranecomputingmodel
AT galanjuanc simulatingtheefficacyofvaccinesontheepidemiologicaldynamicsofsarscov2inamembranecomputingmodel
AT moyaandres simulatingtheefficacyofvaccinesontheepidemiologicaldynamicsofsarscov2inamembranecomputingmodel
AT cantonrafael simulatingtheefficacyofvaccinesontheepidemiologicaldynamicsofsarscov2inamembranecomputingmodel
AT llorenscarlos simulatingtheefficacyofvaccinesontheepidemiologicaldynamicsofsarscov2inamembranecomputingmodel
AT baquerofernando simulatingtheefficacyofvaccinesontheepidemiologicaldynamicsofsarscov2inamembranecomputingmodel